Home / Brands / Watson Laboratories
Watson Laboratories Recalls
22 recalls on record · July 11, 2012 to February 5, 2014 · Drugs
Recalls by year
12
13
14
Count of recall notices naming this brand, by the year the recall was announced. A quiet year is not proof of a safe year.
February 5, 2014DrugsFDA
Watson Laboratories Inc recalls Hydrocodone Bitartrate and Acetaminophen Tablets USP, CIII, 10 mg/ 660 mg, 100 count bottles, Rx only. Manufactured by
Hazard: Failed Tablet/Capsule Specifications; Product contains broken tablets.
January 15, 2014DrugsFDA
Watson Laboratories Inc recalls Carisoprodol Tablets, USP, CIV, 350 mg, 500 count bottle, Rx only. Manufactured by Watson Pharma Private Ltd, Verna, Sal
Hazard: Presence of Foreign Substance; metal particulates were visually observed in the tablets.
October 16, 2013DrugsFDA
Watson Laboratories Inc recalls Next Choice" One Dose Emergency Contraceptive (Levonorgestrel Tablet), 1.5 mg, 1 Tablet/Blister Card (NDC 52544-287-54),
Hazard: Failed Tablet/Capsule Specifications: Multiple complaints for push through tablet breakage.
October 9, 2013DrugsFDA
Watson Laboratories Inc recalls Oxycodone and Acetaminophen Tablets, USP 10 mg/650 mg, CII, 100 Count Bottles, Rx Only, Manufactured by: Watson Laborato
Hazard: Presence of Foreign Tablets/Capsules: 20 tablets of Oxycodone/APAP 7.5/500 mg were found in a sealed 100 count bottle of Oxycodone and Acetaminophen Tablets, USP 10/650 mg lot# 705791A.
September 25, 2013DrugsFDA
Watson Laboratories Inc recalls Hydrocodone Bitartrate and Acetaminophen Tablets, 7.5 mg/650 mg Tablets, 500 Count Bottle, Manufactured by: Watson Labor
Hazard: Defective Container: Defective bottles may not have tamper evident seals properly seated, and therefore it may be difficult to determine if the product had been opened or tampered with.
July 31, 2013DrugsFDA
Watson Laboratories Inc recalls Oxycodone and Acetaminophen Capsules, USP 5mg/500 mg, packaged in a)100-count bottle (NDC 0591-0737-01), b) 500-count bo
Hazard: Subpotent drug: Two lots of Oxycodone and Acetaminophen Capsules, USP 5/500 mg are being recalled due to low out of specification (OOS) assay result obtained at expiry (24 months) for the oxycodone portion of the product.
March 27, 2013DrugsFDA
Watson Laboratories Inc recalls ZARAH¿ Drospirenone/ Ethinyl Estradiol Tablets, 3.0 mg/0.03 mg, Rx only, 3 tablet dispensers, 28 tablets each, Manuf. by
Hazard: Failed Tablet/Capsule Specification; tablet breakage while pushing through the blister pack (dispenser) .
March 27, 2013DrugsFDA
Watson Laboratories Inc recalls Meprobamate; Tablets USP, 400 mg, 100 tablets; Rx only; Manufactured By: Watson Laboratories, Inc., Corona, CA 92800 US
Hazard: Failed Impurities/Degradation Specifications: Watson Laboratories Inc. is recalling meprobamate because an out of specification result for an impurity diphenyl sulfone .
March 27, 2013DrugsFDA
Watson Laboratories Inc recalls Meprobamate, Tablets USP, 200 mg, 100 tablets; Rx only; Manufactured By: Watson Laboratories, Inc., Corona, CA 92800 US
Hazard: Failed Impurities/Degradation Specifications: Watson Laboratories Inc. is recalling meprobamate because an out of specification result for an impurity diphenyl sulfone .
December 26, 2012DrugsFDA
Watson Laboratories Inc recalls Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15
Hazard: Impurities/Degradation Products: Out-of-specification results were obtained for a known impurities.
November 28, 2012DrugsFDA
Watson Laboratories Inc recalls Hydrocodone Bitartrate and Acetaminophen Tablets USP, 10 mg/500 mg, 500-count Tablets per bottle, Rx only, Manufactured
Hazard: Superpotent (Multiple Ingredient) Drug: There is the potential for oversized and superpotent tablets.
October 31, 2012DrugsFDA
Watson Laboratories Inc recalls Necon 1/35-28 (norethindrone and ethinyl estradiol) Tablets USP, 1 mg/35 mcg, inert tablets, 28-count tablets per dispen
Hazard: Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).
October 31, 2012DrugsFDA
Watson Laboratories Inc recalls Necon 10/11 (norethindrone and ethinyl estradiol) Tablets USP, 0.5 mg/35 mcg, 1 mg/35 mcg, inert tablets, 28-count table
Hazard: Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).
October 31, 2012DrugsFDA
Watson Laboratories Inc recalls Zenchent (norethindrone and ethinyl estradiol) Tablets USP, 0.4 mg/0.035 mg, 28-count tablets per dispenser packaged in
Hazard: Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).
October 31, 2012DrugsFDA
Watson Laboratories Inc recalls Lutera (levonorgestrel and ethinyl estradiol) Tablets USP, 0.1 mg/0.02 mg, inert tablets, 28-count tablets per dispenser
Hazard: Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).
October 31, 2012DrugsFDA
Watson Laboratories Inc recalls Zovia (ethynodiol diacetate and ethinyl estradiol) Tablets USP, 1 mg/35 mcg, inert tablets, 28-count tablets per dispens
Hazard: Cross Contamination With Other Products: The firm recalled Zovia, Lutera, Necon, and Zenchent, because certain lots could potentially be contaminated with trace amounts of Hydrochlorothiazide (HCTZ).
August 8, 2012DrugsFDA
Watson Laboratories Inc recalls Caziant (desogestrel and ethinyl estradiol) Tablets, USP, (Triphasic Regimen), 0.1 mg/0.025 mg, 0.125 mg/0.025 mg, 0.15
Hazard: Impurities/Degradation Products: High Out-of-specification results were obtained for both known and unknown impurities.
July 11, 2012DrugsFDA
Watson Laboratories Inc recalls Loxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle, Rx only, Watson Laboratories Inc., Coron
Hazard: Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.
July 11, 2012DrugsFDA
Watson Laboratories Inc recalls Loxapine Capsules USP, 50mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC #
Hazard: Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.
July 11, 2012DrugsFDA
Watson Laboratories Inc recalls Loxapine Capsules USP, 25mg, 100 count bottle, Rx only, Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC
Hazard: Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.
July 11, 2012DrugsFDA
Watson Laboratories Inc recalls Loxapine Capsules USP, 10mg, 100 count bottle, Rx only, Manufactured By: Watson Laboratories Inc., Corona, CA 92880 Rx o
Hazard: Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.
July 11, 2012DrugsFDA
Watson Laboratories Inc recalls Loxapine Capsules USP, 5mg, 100 count bottle, Rx only Manufactured By: Watson Laboratories Inc., Corona, CA 92880 NDC #
Hazard: Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.